esmo 2020 highlights on blocking pi3k/akt signalling pathway in mcrpc: the ipatential150 study
Published 4 years ago • 1.7K plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
3:25
highlights on lu-psma-617 in taxane-naive patients with mcrpc: the psmafore study
-
8:51
esmo 2020 expert video report on precision medicine in prostate cancer
-
1:00:07
pi3k/akt pathway inhibition for the treatment of metastatic castrate-resistant prostate cancer
-
3:49
esmo highlights: genitourinary cancers
-
2:45
esmo 2020 highlights on neoadjuvant mfolfirinox for t3-4 rectal cancer: the prodige 23 study
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
6:30
esmo congress 2024 gu round-up: prostate cancer
-
24:35
esmo 2024: highlights and analysis
-
18:34
drs. karine tawagi and samantha armstrong recap esmo 2024
-
1:00:07
pi3k/akt pathway inhibition for metastatic castrate-resistant prostate cancer
-
2:21
#esmo22 highlights on adt duration with post-operative radiotherapy in prostate cancer: radicals-hd
-
3:04
esmo 2020 highlights on durability of clinical benefit and biomarkers with amg510 in nsclc
-
0:27
esmo congress 2019 daily reporter - editor's picks: prostate cancer
-
0:52
defining oligometastatic disease, and its impact on treatment in prostate cancer: 2022 esmo florida
-
0:52
clinical trial updates in prostate cancer at esmo 2022
-
3:09
prostate cancer updates at esmo 2021: stampede and peace-1
-
1:06
esmo 2021 highlights in colorectal cancer
-
1:19
highlights in prostate cancer from esmo
-
1:21
prostate cancer research at esmo 2020: christopher sweeney, mbbs
-
1:22
jarrod longcor: esmo highlights